Home › Uterine Cancer › Texas
Uterine Cancer clinical trials in Texas
10 studies for Uterine Cancer are looking for participants at sites in Texas.
Cities in Texas
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Texas Oncology - DFW, Arlington
- Texas Oncology - Central South, Austin
- Texas Oncology - Central South, Austin
- and 13 more
RecruitingPhase 4
Ages 18 and older · Women · Updated Sep 25, 2026 · NCT06952660Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
- M D Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 18, 2026 · NCT04038619Sentinel Node Biopsy in Endometrial Cancer
- Houston Methodist Hospital, Houston
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 15, 2026 · NCT04073706DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Austin
- Research Site, Fort Worth
- Research Site, Houston
- and 1 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Sep 3, 2026 · NCT06989112Investigations of Reproductive Cancers in Women
- Baylor College of Medicine/Texas Children's Hospital, Houston
- Houston Methodist, Houston
- University of Texas Health Science Center at San Antonio, San Antonio
RecruitingObservational study
Ages 45 to 100 · Women · Updated Aug 17, 2026 · NCT06527157Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Texas Oncology, Abilene
- Texas Oncology - Central / South Texas, Austin
- Mary Crowley Cancer Research, Dallas
- and 3 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT05579366Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Austin
- Research Site, Houston
- Research Site, Tyler
RecruitingPhase 3
Ages 18 and older · Women · Updated Jul 29, 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Baylor Scott & White Research Institute, Dallas
- University of Texas MD Anderson Cancer Center, Houston
- Baylor Scott & White Medical Center, Temple
RecruitingPhase 2
Ages 8 and older · All sexes · Updated Jul 27, 2026 · NCT05503797Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · Women · Updated May 6, 2026 · NCT05049538Sample Collection for Ongoing Research and Product Evaluation Study
- Natera, Inc., Austin
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 15, 2026 · NCT07318051From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.